Safety, Tolerability, and Preliminary Effectiveness of CTH120 in Fragile X Syndrome

NCT07654114 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Connecta Therapeutics, S.L.

Collaborators